ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,303 | +121.6% | 21,574 | 0.0% | 0.00% | – |
| Q1 2023 | $15,477 | -88.2% | 21,574 | +61.0% | 0.00% | -100.0% |
| Q1 2020 | $131,000 | -88.4% | 13,396 | -86.4% | 0.00% | -87.5% |
| Q4 2019 | $1,133,000 | +180.4% | 98,373 | +32.7% | 0.01% | +166.7% |
| Q3 2019 | $404,000 | +45.3% | 74,127 | +216.9% | 0.00% | 0.0% |
| Q2 2019 | $278,000 | +13800.0% | 23,391 | +3642.6% | 0.00% | – |
| Q4 2018 | $2,000 | -98.1% | 625 | -96.5% | 0.00% | -100.0% |
| Q1 2018 | $104,000 | +116.7% | 18,008 | +30.7% | 0.00% | – |
| Q4 2017 | $48,000 | +128.6% | 13,776 | +134.4% | 0.00% | – |
| Q3 2017 | $21,000 | +23.5% | 5,876 | -14.8% | 0.00% | – |
| Q2 2017 | $17,000 | -10.5% | 6,895 | 0.0% | 0.00% | – |
| Q1 2017 | $19,000 | +26.7% | 6,895 | +30.1% | 0.00% | – |
| Q4 2016 | $15,000 | +66.7% | 5,298 | +141.0% | 0.00% | – |
| Q3 2016 | $9,000 | -79.5% | 2,198 | -84.3% | 0.00% | -100.0% |
| Q2 2016 | $44,000 | – | 13,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $85,866,000 | 42.72% |
| Versant Venture Management, LLC | 7,003,892 | $146,241,265,000 | 21.01% |
| ACUTA CAPITAL PARTNERS, LLC | 1,746,500 | $36,467,000 | 10.54% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $10,022,000 | 5.33% |
| Ghost Tree Capital, LLC | 900,000 | $18,792,000 | 4.96% |
| RTW INVESTMENTS, LP | 6,790,027 | $141,776,000 | 3.99% |
| RA Capital Management | 7,801,641 | $162,898,000 | 3.17% |
| Avoro Capital Advisors LLC | 7,585,000 | $158,375,000 | 3.13% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $30,005,000 | 2.64% |
| Soleus Capital Management, L.P. | 218,723 | $4,566,000 | 2.60% |